# FDA 483 - Evaric Pharmaceuticals Inc. - May 24, 2026

Source: https://www.keypedia.com/records/483/evaric-pharmaceuticals-inc/5ab8706f-a525-42ea-bd9d-126d9ab69f62

> FDA 483 for Evaric Pharmaceuticals Inc. on May 24, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Evaric Pharmaceuticals Inc.
- Inspection Date: 2026-05-24
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: Evaric Pharmaceuticals Inc. in Hauppauge, NY, underwent an FDA inspection as a drug manufacturer. The inspection revealed that the firm is not prepared for the manufacture of a specific drug product, as a critical piece of equipment, a blender, required for commercial production was not physically present at the facility. This indicates a significant readiness issue for the intended manufacturing process.

## Related Documents

- [483 - 2021-03-01](https://www.keypedia.com/records/483/evaric-pharmaceuticals-inc/d0eacb43-309d-43c7-9db0-271c05fec4cf)
- [483 - 2025-05-16](https://www.keypedia.com/records/483/evaric-pharmaceuticals-inc/28b43d71-7b81-4187-8f7f-9182f64170bc)

## Related Officers

- [investigator](https://www.keypedia.com/people/jay-wong/d58065c6-6c52-4d77-af6b-089176c778c9)

Company: https://www.keypedia.com/companies/evaric-pharmaceuticals-inc/0f29a015-1b48-40b9-a0a7-04ec9c3e15b4

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961